Virbagen Omega Եվրոպական Միություն - բուլղարերեն - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - рекомбинантен омега интерферон от котешки произход - Иммуностимуляторы, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. При котки, заразени с fiv, смъртността е ниска (5%) и не е повлияна от лечението.

Amoksiklav  125 mg/31,25 mg/5 ml powder for oral suspension Բուլղարիա - բուլղարերեն - Изпълнителна агенция по лекарствата

amoksiklav  125 mg/31,25 mg/5 ml powder for oral suspension

lek, pharmaceuticals d.d. - Амоксицилин и инхибитор на ензима - 125 mg/31,25 mg/5 ml powder for oral suspension

Amoksiklav  250 mg/ 62,5 mg/5 ml powder for oral suspension Բուլղարիա - բուլղարերեն - Изпълнителна агенция по лекарствата

amoksiklav  250 mg/ 62,5 mg/5 ml powder for oral suspension

lek, pharmaceuticals d.d. - Амоксицилин и инхибитор на ензима - 250 mg/ 62,5 mg/5 ml powder for oral suspension

Amoksiklav  400 mg/ 57 mg/5 ml powder for oral suspension Բուլղարիա - բուլղարերեն - Изпълнителна агенция по лекарствата

amoksiklav  400 mg/ 57 mg/5 ml powder for oral suspension

lek pharmaceuticals d.d.. - Амоксицилин и инхибитор на ензима - 400 mg/ 57 mg/5 ml powder for oral suspension